Business Trends– category –
-
NueCell Bio Unveils 26,300 Sq Ft Cell Therapy Development Facility in San Diego, Bolstering Clinical & Commercial Manufacturing
PharmaSource USA Overview NueCell Bio has officially opened its 26,300-square-foot cell therapy development facility in San Diego, significantly enhancing its clinical and commercial manufacturing capabilities. The state-of-the-art facil... -
Japan’s Regenerative Medicine Regulated by Two Pillars: Approved Cell Products and Registered Private Treatments, Emphasizing Safety and Quality
Stem Cell Clarity Japan Overview Japanese regenerative medicine is governed by two distinct legal frameworks: cell products approved by the Minister of Health, Labour and Welfare, and private treatments under a registration system where ... -
Oxford Biomedica Launches Fast-Track Viral Vector Service, Accelerating Gene Therapy Development by Cutting Manufacturing Times by up to 8 Months
Kalkine UK Overview Oxford Biomedica has launched a fast-track viral vector service to accelerate gene therapy development. This new service shortens GMP-grade manufacturing for AAV vectors from approximately 15 months to as little as 7 ... -
Texas Children’s Hospital’s GMP Facility Manufactures Over 10,000 Cell Therapy Products in 20 Years, Driving CGT Innovation
Texas Children's Hospital USA Overview Texas Children's Hospital's Center for Cell and Gene Therapy (CAGT) has manufactured over 10,000 cell therapy products and more than 70 clinical-grade viral vectors over two decades, utilizing its i... -
Biologics and GLP-1 Agonists Drive Acceleration of Automation and Digitization in Fill-Finish Manufacturing
BioProcess Online USA Overview The rapid rise of biologics—including antibody-drug conjugates (ADCs), cell & gene therapies, and mRNA products—and GLP-1 receptor agonists is accelerating the evolution of fill-finish manufacturing pro... -
CellFiber and Tidewave Bio Partner to Evaluate 3D Cell Culture Platform for Scalable Manufacturing of Next-Gen Cell Immunotherapies
BioProcess International Global Overview CellFiber and Tidewave Bio have initiated a joint Proof of Concept (PoC) to evaluate CellFiber's 3D cell culture platform for scalable manufacturing of Tidewave's next-generation cell immunotherap... -
Aternium Plans Clean Hydrogen Production in Dover, Delaware, Using Zero-Emission Power Without Federal Aid
Delaware Public Media USA Overview Aternium announced plans to produce clean hydrogen in Dover, Delaware, utilizing zero-emission power sources like wind, solar, and nuclear, without relying on federal government support. The company exp... -
U.S. DOE Hydrogen and Fuel Cell Technologies Office (HFTO) Announces Funding Opportunity to Advance National Clean Hydrogen Strategy
HigherGov USA Overview The U.S. Department of Energy (DOE)'s Office of Energy Efficiency and Renewable Energy (EERE), on behalf of the Hydrogen and Fuel Cell Technologies Office (HFTO), has announced a Funding Opportunity Announcement (F... -
Europe Fuels Green Hydrogen Future with Over $1 Billion Investment: Spain, Netherlands Lead the Charge
pv magazine Spain/Netherlands Overview Europe is significantly accelerating its green hydrogen ambitions with over $1 billion in new funding. Spain has committed €274.2 million to establish 102.27 MW of electrolysis capacity, while the N... -
LANXESS First to Deploy Hydrogen Fuel in Industrial Process at Krefeld-Uerdingen Plant, Cutting 6,000 Tons CO2 Annually
NewswireToday Germany Overview German specialty chemicals manufacturer LANXESS has for the first time utilized hydrogen as fuel in an industrial process at its Krefeld-Uerdingen plant, enhancing production sustainability. The company exp...
